REPL vs SNPS
Replimune Group Inc (REPL) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
REPL does not have a complete income-statement cache yet.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
REPL currently screens at market cap $825.7M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the REPL and SNPS stock pages for the full models.
Not investment advice.